Ranbaxy, Virchow Launch Bonista Generic In India
This article was originally published in PharmAsia News
Ranbaxy Laboratories and Virchow Biotech have launched a generic version of Bonista (teriparatide) injectable for treating osteoporosis. The drug was developed in part with aid from India's Department of Science and Technology. The treatment is based on the recombinant human parathyroid hormone. (Click here for more
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.